Expert Ratings For OptimizeRx
Expert Ratings For OptimizeRx
OptimizerX 的專家評級
OptimizeRx (NASDAQ:OPRX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師對OptimizerX（納斯達克股票代碼：OPRX）進行了分析，揭示了從看漲到看跌的不同觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $14.6, with a high estimate of $17.00 and a low estimate of $13.00. This current average has increased by 12.31% from the previous average price target of $13.00.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標爲14.6美元，最高估計爲17.00美元，低估值爲13.00美元。目前的平均價格較之前的平均目標價13.00美元上漲了12.31％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
The analysis of recent analyst actions sheds...
對分析師近期行...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。